ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

NCCS Names 7 To Board; FDA Approves Warning Labels for Hormone Therapy

January 17, 2003

Breast Cancer Coalition Plans Petition Urging Comprehensive Strategy

May 14, 1993

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

In Brief: Senate Committee Finishes Work On Renewal Bill, Both Houses (So Far) Leave NCI Authorities Intact

May 21, 1982